Laboratory Services

West Nile Virus Antibody, IgG and IgM, Serum

Print this page

Updated Test Information:

Test Description
West Nile Virus Antibody, IgG and IgM, Serum
Synonym(s)

Arbovirus, Flavivirus, Mosquito borne encephalitis, Viral encephalitis, West Nile virus (WNV)

Test ID
WNS
General Information

Laboratory diagnosis of infection with West Nile virus in serum specimens


HIGHLIGHTS
Detection of antibodies to West Nile virus (WNV) in serum can be used to support the diagnosis of recent WNV infection. This test should be used for diagnostic purposes only.

Container Type

Preferred: SST
Acceptable: Red Top Tube

Specimen Type

Serum

Specimen Requirements

0.5 mL

Specimen Collection / Processing Instructions

SST: Centrifuge within 2 hours of collection. 
Red Top Tube: Centrifuge within 2 hours of collection and aliquot into a plastic tube.

Minimum Sample Volume

0.4mL

Stability

Refrigerated (preferred): 14 Days, Frozen: 14 Days

Unacceptable Specimen Conditions

Gross hemolysis, Gross lipemia, Gross icterus, Heat Inactivated specimen

Methodology

Enzyme-Linked Immunosorbent Assay (ELISA)


IgG: Polystyrene microwells are coated with recombinant West Nile virus (WNV) antigen. Diluted serum specimens and controls are incubated in the wells to allow specific antibody present in the specimens to react with the antigen. Nonspecific reactants are removed by washing, and peroxidase-conjugated antihuman IgG is added and reacts with specific IgG. Excess conjugate is removed by washing. Enzyme substrate and chromogen are added, and the color is allowed to develop. After adding the stop reagent, the resultant color change is quantified by a spectrophotometric reading of optical density (OD). Specimen OD readings are compared with reference cutoff readings to determine results.(Package insert: Flavivirus [West Nile] ELISA IgG. Focus Technologies;10/16/2012)


IgM: Polystyrene microwells are coated with the antihuman antibody specific for IgM (u-chain). Diluted serum specimens and controls are incubated in the wells, and IgM present in the specimen binds to the antihuman antibody (IgM specific) in the wells. Nonspecific reactants are removed by washing. WNV antigen is then added to the wells and incubated. If anti-WNV IgM is present in the specimen, the WNV antigen binds to the anti-WNV in the well. Unbound WNV antigen is then removed by washing the well. Mouse antiflavivirus conjugated with horseradish peroxidase (HRP) is then added to the wells and incubated. If WNV antigen has been retained in the well by the antiflavivirus in the specimen, the mouse antiflavivirus:HRP binds to WNV antigen in the wells. Excess conjugate is removed by washing. Enzyme substrate and chromogen are added, and the color is allowed to develop. After adding the Stop reagent, the resultant color change is quantified by a spectrophotometric reading of OD that is directly proportional to the amount of antigen-specific IgM present in the specimen. Specimen OD readings are compared with reference cutoff OD readings to determine results.(Package insert: Flavivirus [West Nile] IgM Capture ELISA. Focus Technologies; 06/01/2015)

Estimated TAT

2-5 Days

Testing Schedule

Monday, Wednesday, Friday

Test Includes

WNGS       West Nile Virus Ab, IgG, S 
WNMS      West Nile Virus Ab, IgM, S 
WNVSI      West Nile Serum Interpretation

Retention

14 Days

CPT Code(s)

IgG-86789
IgM-86788

Reference Range

IgG: negative
IgM: negative

Reference values apply to all ages

Performing Lab

Mayo

LOINC Code(s)

Test Id                   Test Order Name                                               Order LOINC Value
WNS                      West Nile Virus Ab, IgG and IgM, S         94854-7

Result Id             Test Result Name                                       Result LOINC Value
WNGS                 West Nile Virus Ab, IgG, S                     29566-7
WNMS                West Nile Virus Ab, IgM, S                    29567-5
WNVSI                West Nile Serum Interpretation       69048-7

Additional Information

Test results should be used in conjunction with a clinical evaluation and other available diagnostic procedures.

The significance of negative test results in immunosuppressed patients is uncertain.

Positive test results may not be valid in persons who have received blood transfusions or other blood products within the past several months.

False-negative results due to competition by high levels of IgG, while theoretically possible, have not been observed.

False-positive results may occur in persons vaccinated for flaviviruses (eg, yellow fever, Japanese encephalitis, dengue)

False-positive results may occur in patients infected with other arboviruses, including flaviviruses (eg, dengue virus) and alphavirusis (eg, LaCrosse [California] Encephalitis virus, Eastern or Western equine encephalitis virus, St. Louis virus) and in persons previously infected with West Nile virus (WNV).

Because closely related arboviruses exhibit serologic cross-reactivity, it sometimes may be epidemiologically important to attempt to pinpoint the infecting virus by conducting cross-neutralization tests using an appropriate battery of closely related viruses.

WNV antibody results for cerebrospinal fluid (CSF) should be interpreted with caution. Complicating factors include low antibody levels found in CSF, passive transfer of antibody from blood, and contamination via a traumatic lumbar puncture.